Order Article Reprints

Wijaya YOS, Niba ETE, Nishio H, Okamoto K, Awano H, Saito T, Takeshima Y, Shinohara M. High Concentration or Combined Treatment of Antisense Oligonucleotides for Spinal Muscular Atrophy Perturbed SMN2 Splicing in Patient Fibroblasts. Genes. 2022; 13(4):685. https://doi.org/10.3390/genes13040685

Wijaya, Yogik Onky Silvana, Emma Tabe Eko Niba, Hisahide Nishio, Kentaro Okamoto, Hiroyuki Awano, Toshio Saito, Yasuhiro Takeshima, and Masakazu Shinohara. 2022. "High Concentration or Combined Treatment of Antisense Oligonucleotides for Spinal Muscular Atrophy Perturbed SMN2 Splicing in Patient Fibroblasts" Genes 13, no. 4: 685. https://doi.org/10.3390/genes13040685

Wijaya, Y. O. S., Niba, E. T. E., Nishio, H., Okamoto, K., Awano, H., Saito, T., Takeshima, Y., & Shinohara, M. (2022). High Concentration or Combined Treatment of Antisense Oligonucleotides for Spinal Muscular Atrophy Perturbed SMN2 Splicing in Patient Fibroblasts. Genes, 13(4), 685. https://doi.org/10.3390/genes13040685